R3R01

· River 3 Renal Corp.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for R3R01, covering 2025-09-29 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: The Evaluation of the Drug R3R01 for the Excretion of Protein in the Urine in Patients With Diabetic Kidney Disease. [Phase 2]

See pricing